• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Walgreens Plans 'Significant' Store Closures As It Faces 'Difficult Operating Environment'

    6/27/24 1:03:52 PM ET
    $CVS
    $WAB
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Railroads
    Industrials
    Get the next $CVS alert in real time by email

    Walgreens expects to close a “significant” number of stores in the face of “headwinds,” but the pharmacy chain has not specified how many retail locations it plans to shutter.

    Parent company Walgreen Boots Alliance, Inc. (NASDAQ:WBA) announced the plan to close an undisclosed number of its roughly 8,700 stores on Thursday when it released earnings for this year’s third quarter.

    The Deerfield, Illinois-based retailer said it was “finalizing [a] significant multiyear footprint optimization program to close certain underperforming U.S. stores” as part of an update to a strategic review outlined in its earnings release.

    Walgreens did not make further mention of the planned closures in the release, but CEO Tim Wentworth acknowledged that the company was dealing with challenges.

    Also read: Walgreens Boots Alliance Unusual Options Activity

    “We continue to face a difficult operating environment, including persistent pressures on the U.S. consumer and the impact of recent marketplace dynamics which have eroded pharmacy margins,” he said in a statement.

    “Our results and outlook reflect these headwinds, despite solid performance in both our International and U.S. Healthcare segments.”

    He also said that Walgreens is focused on its core business retail pharmacy as it strives for a business turnaround.

    “We are addressing critical issues with urgency and working to unlock opportunities for growth,” he said.

    Walgreens posted $344 million in net profit for the third quarter, up from a $118 million profit posted during the same period last year.

    Rite Aid Corporation (OTC:RADCQ) is also facing difficulties as it goes through bankruptcy proceedings. The pharmacy chain will ask a U.S. bankruptcy court to approve a restructuring plan on Thursday aimed at reducing $2 billion in debt and transferring control of the company to a group of its lenders, Reuters reported.

    Price Action: Walgreen’s shares were down 25% to $11.73 at the time of publication Thursday.

    Read Next:

    • Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute

    Photo: refrina/Shutterstock.com

    Get the next $CVS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVS
    $WAB
    $WBA

    CompanyDatePrice TargetRatingAnalyst
    Westinghouse Air Brake Technologies Corporation
    $WAB
    1/8/2026$245.00Peer Perform → Outperform
    Wolfe Research
    CVS Health Corporation
    $CVS
    10/14/2025$91.00Buy
    Goldman
    Westinghouse Air Brake Technologies Corporation
    $WAB
    9/22/2025$225.00Buy
    Citigroup
    CVS Health Corporation
    $CVS
    8/18/2025$79.00Neutral → Buy
    UBS
    CVS Health Corporation
    $CVS
    8/14/2025$82.00Neutral → Outperform
    Robert W. Baird
    Westinghouse Air Brake Technologies Corporation
    $WAB
    4/10/2025$175.00Neutral
    Analyst
    Walgreens Boots Alliance Inc.
    $WBA
    2/28/2025$11.00 → $9.00Hold → Sell
    Deutsche Bank
    CVS Health Corporation
    $CVS
    2/13/2025$55.00 → $75.00Market Perform → Outperform
    Leerink Partners
    More analyst ratings

    $CVS
    $WAB
    $WBA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and President, Aetna Nelson Steven H bought $1,289 worth of shares (24 units at $53.70) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    1/27/26 5:20:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    EVP and Chief People Officer Capozzi Heidi B bought $4,589 worth of shares (80 units at $57.36) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Sansone Guy P bought $100,009 worth of shares (1,570 units at $63.70), increasing direct ownership by 15% to 12,007 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/9/25 8:22:46 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $WAB
    $WBA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres., Global Freight Services Gaur Sameer covered exercise/tax liability with 274 shares, decreasing direct ownership by 2% to 10,999 units (SEC Form 4)

    4 - WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP (0000943452) (Issuer)

    2/3/26 7:20:34 PM ET
    $WAB
    Railroads
    Industrials

    New insider Gaur Sameer claimed ownership of 11,273 shares (SEC Form 3)

    3 - WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP (0000943452) (Issuer)

    2/3/26 7:18:35 PM ET
    $WAB
    Railroads
    Industrials

    EVP and President, Aetna Nelson Steven H bought $1,289 worth of shares (24 units at $53.70) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    1/27/26 5:20:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $WAB
    $WBA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Wabtec Declares Regular Quarterly Common Dividend

    Wabtec Corporation (NYSE:WAB) announced today that its Board of Directors declared a regular quarterly common dividend of 31 cents per share, payable on March 2, 2026, to holders of record on February 17, 2026. About Wabtec Wabtec Corporation is revolutionizing the way the world moves for future generations. The Company is a leading global provider of equipment, systems, digital solutions and value-added services for the freight and transit rail industries, as well as the mining, marine and industrial markets. Wabtec has been a leader in the rail industry for 155 years and has a vision to achieve an efficient rail system in the U.S. and worldwide. Visit Wabtec's website at http://www.wabt

    2/6/26 4:10:00 PM ET
    $WAB
    Railroads
    Industrials

    CVS Pharmacy Now Accepting TrumpRx Discount Cards

    WOONSOCKET, R.I., Feb. 6, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced that its approximately 9,000 community pharmacies are accepting TrumpRx discount cards, which offer savings on certain medications for those who are eligible, as determined by the drug manufacturers. Eligible patients can bring their printed discount cards and savings can be applied at the pharmacy counter. CVS Pharmacy and its 27,000 community pharmacists across the country are available to support customers by providing information and insight on how to save more on medications. In addition

    2/6/26 4:08:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Aetna, a CVS Health company, receives Health Plan of the Year Award from Press Ganey

    Press Ganey's inaugural Health Plan of the Year award recognizes Aetna's sustained excellence across member experience, quality performance and provider collaboration. HARTFORD, Conn., Feb. 5, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE:CVS), today announced that Press Ganey recognized Aetna as its first-ever Health Plan of the Year at their annual Human Experience (HX26) Conference in Orlando, Florida. Press Ganey, the leading provider of experience measurement, data analytics and AI-powered insights to health systems and health plans, presented the award to Steve Nelson, president of Aetna.

    2/5/26 4:00:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $WAB
    $WBA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wabtec upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Wabtec from Peer Perform to Outperform and set a new price target of $245.00

    1/8/26 8:14:43 AM ET
    $WAB
    Railroads
    Industrials

    Goldman initiated coverage on CVS Health with a new price target

    Goldman initiated coverage of CVS Health with a rating of Buy and set a new price target of $91.00

    10/14/25 8:48:20 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Citigroup initiated coverage on Wabtec with a new price target

    Citigroup initiated coverage of Wabtec with a rating of Buy and set a new price target of $225.00

    9/22/25 8:32:52 AM ET
    $WAB
    Railroads
    Industrials

    $CVS
    $WAB
    $WBA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $WAB
    $WBA
    SEC Filings

    View All

    SEC Form 144 filed by Westinghouse Air Brake Technologies Corporation

    144 - WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP (0000943452) (Subject)

    12/12/25 4:07:52 PM ET
    $WAB
    Railroads
    Industrials

    CVS Health Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CVS HEALTH Corp (0000064803) (Filer)

    12/9/25 6:33:11 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 8-K filed by CVS Health Corporation

    8-K - CVS HEALTH Corp (0000064803) (Filer)

    11/20/25 4:18:11 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $WAB
    $WBA
    Leadership Updates

    Live Leadership Updates

    View All

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care

    Providing access to affordable care $0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1, $0 copay for colonoscopies and mammograms at in-network providers$0 copay for annual Healthy Home Visit from a licensed Signify Health clinicianContinued investment in technology, tools and teams that support our members Commitment to supporting unique member needs — those living with chronic conditions and individuals dually eligible for both Medicare and MedicaidLeveraging the strength of the CVS Health family of companies to deliver differentiated member experiencesWOONSOCKET, R.I., Oct. 1, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2026 Medi

    10/1/25 7:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Walgreen Co. To Operate as Private Standalone Company Following Acquisition By Sycamore Partners

    Appoints Mike Motz as Chief Executive Officer Walgreen Co. ("Walgreens", or the "Company"), America's leading independent retail pharmacy, announced today that it is now operating as a private standalone company following its acquisition by Sycamore Partners ("Sycamore"), a leading private equity firm based in New York. Sycamore is acquiring the business in partnership with Stefano Pessina and his family, who have reinvested 100% of their interests in Walgreens, demonstrating their ongoing support and confidence in the Company's future. Mike Motz has been appointed as Chief Executive Officer of Walgreens effective immediately. Motz was formerly CEO of Staples US Retail, a Sycamore por

    8/28/25 8:31:00 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $WAB
    $WBA
    Financials

    Live finance-specific insights

    View All

    Wabtec Declares Regular Quarterly Common Dividend

    Wabtec Corporation (NYSE:WAB) announced today that its Board of Directors declared a regular quarterly common dividend of 31 cents per share, payable on March 2, 2026, to holders of record on February 17, 2026. About Wabtec Wabtec Corporation is revolutionizing the way the world moves for future generations. The Company is a leading global provider of equipment, systems, digital solutions and value-added services for the freight and transit rail industries, as well as the mining, marine and industrial markets. Wabtec has been a leader in the rail industry for 155 years and has a vision to achieve an efficient rail system in the U.S. and worldwide. Visit Wabtec's website at http://www.wabt

    2/6/26 4:10:00 PM ET
    $WAB
    Railroads
    Industrials

    Wabtec Announces Fourth Quarter 2025 Earnings Release Date

    Wabtec Corporation (NYSE:WAB) announced it will report 2025 fourth quarter results before the U.S. financial markets open on February 11, 2026. The company will conduct a conference call to discuss those results with analysts and investors at 8:30 a.m. ET the same day. To listen to the call via webcast, visit Wabtec's website at www.WabtecCorp.com and click on "Events & Presentations" in the "Investor Relations" section. An audio replay of the call will be available by calling 1-855-669-9658 or 1-412-317-0088 (access code: 8243971). About Wabtec Corporation Wabtec Corporation is revolutionizing the way the world moves for future generations. The Company is a leading global provider of e

    1/16/26 8:00:00 AM ET
    $WAB
    Railroads
    Industrials

    CVS Health to hold fourth quarter and full year 2025 earnings conference call

    WOONSOCKET, R.I., Jan. 15, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Tuesday, February 10th, 2026, at 8:00 a.m. ET to discuss fourth quarter and full year 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of S

    1/15/26 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $WAB
    $WBA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Westinghouse Air Brake Technologies Corporation

    SC 13G/A - WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP (0000943452) (Subject)

    11/14/24 1:22:37 PM ET
    $WAB
    Railroads
    Industrials

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Westinghouse Air Brake Technologies Corporation

    SC 13G/A - WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP (0000943452) (Subject)

    11/8/24 10:34:33 AM ET
    $WAB
    Railroads
    Industrials